Sfoglia per AUTORE
SARZI-PUTTINI P
Collezione AO Ordine Mauriziano

  

Items : 8

Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Mar-Apr;39(2):263-268. doi: 10.55563/clinexprheumatol/q69z52. Epub 2020 Jun
2021
AOU Alessandria
AO Ordine Mauriziano

Stobbione P; Capri S; Sinigaglia L; Sarzi-Puttini P; Fusaro E; Gorla R; Lomater C; Caporali R; Manara M;

Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors. in Autoimmunity reviews / Autoimmun Rev. 2020 May;19(5):102509. doi: 10.1016/j.autrev.2020.102509. Epub 2020 Mar 12.
2020
AO Ordine Mauriziano

Bodio C; Grossi C; Pregnolato F; Favalli EG; Biggioggero M; Marchesoni A; Murgo A; Filippini M; Migliorini P; Caporali R; Pellerito R; Ciccia F; Sarzi-Puttini P; Perosa F; Paolazzi G; Hollan I; Bendtzen K; Meroni PL; Borghi MO;

The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2018 Apr;47(5):619-629. doi: 10.1016/j.semarthrit.2017.09.013. Epub 2017 Sep
2018
AO Ordine Mauriziano

Salaffi F; Di Carlo M; Iannone F; Fedele AL; Epis OM; Pellerito R; Foti R; Passiu G; Punzi L; Furini F; Sarzi-Puttini P; Carletto A; Gremese E; Lapadula G; Ferraccioli G;

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Jul-Aug;35(4):660-665. Epub 2017 May 8.
2017
AO Ordine Mauriziano

Codullo V; Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G; Caporali R;

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. in Clinical rheumatology / Clin Rheumatol. 2017 Apr;36(4):753-761. doi: 10.1007/s10067-016-3528-y. Epub 2017 Jan 5.
2017
AO Ordine Mauriziano

Monti S; Klersy C; Gorla R; Sarzi-Puttini P; Atzeni F; Pellerito R; Fusaro E; Paolazzi G; Rocchetta PA; Favalli EG; Marchesoni A; Caporali R;

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability. in Clinical rheumatology / Clin Rheumatol. 2016 Nov;35(11):2649-2656. doi: 10.1007/s10067-016-3349-z. Epub 2016 Jul 14.
2016
AO Ordine Mauriziano

Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Caporali R; Codullo V; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G;

2016
AO Ordine Mauriziano

Varisco V; Viganò M; Batticciotto A; Lampertico P; Marchesoni A; Gibertini P; Pellerito R; Rovera G; Caporali R; Todoerti M; Covelli M; Notarnicola A; Atzeni F; Sarzi-Puttini P;

Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey. in Arthritis research & therapy / Arthritis Res Ther. 2016 Apr 1;18:78. doi: 10.1186/s13075-016-0977-2.
2016
AO Ordine Mauriziano

Ramonda R; Marchesoni A; Carletto A; Bianchi G; Cutolo M; Ferraccioli G; Fusaro E; De Vita S; Galeazzi M; Gerli R; Matucci-Cerinic M; Minisola G; Montecucco C; Pellerito R; Salaffi F; Paolazzi G; Sarzi-Puttini P; Scarpa R; Bagnato G; Triolo G; Valesini G; Punzi L; Olivieri I;